From: "Jeffrey E." <[email protected]>

From: "Jeffrey E." <[email protected]> To: Richard Kahn • Subject: Fwd: P5 Health Ventures Date: Fri, 06 Jan 2017 15:12:14 +0000 Forwarded message From: Aaron Moskowitz < Date: Fri, Jan 6, 2017 at 9:24 AM Subject: Re: P5 Health Ventures To: Jeffrey Epstein <[email protected]> Cc: Charlotte Dequeker Dear Jeffrey, Happy New Year. On January 27th, 2017, David and I are holding the first close of the P5 Health Ventures Fund. We appreciate your commitment and want to make the document process as simple as possible. Under separate cover, Charlotte Dequeker, our director of investor relations, will forward the Private Placement Memorandum, Investor Questionnaire and Subscription Document. As per the instructions, they are to be returned to the fund's administrator, Fleming Financial. Further, we will be down in Palm Beach the week of January 16th and if you are in town and have time, we would be happy to sit down and discuss what we are doing. For your records, below are the contact information for Charlotte and our fund administrator, Fleming Financial. Regards, Aaron John Lentz > On Oct 18, 2016, at 10:31 AM, Jeffrey E. <[email protected]> wrote: > im in for a couple of million , > On Tue, Oct 18, 2016 at 10:29 AM, Aaron Moskowitz < > wrote: > I will send the term sheet later and subscription documents this afternoon. > SUMMARY OF TERMS > Fund Size: $25M ($35M cap) > Minimum Commitment Size: $250,000 > Term of Partnership: 8 years with two one-year extensions EFTA01057145 > Investment Period: 4 years > GP Commitment: Minimum $1M or 5% of capital > Extended GP Commitment: Minimum $3M or 10% of capital > Co-Investments: Yes, on a deal by deal basis > Fees and Compensation Allocations > Management Fees: 2% per annum, payable quarterly ahead > Carried Interest: 20% (American Waterfall with Ratchets) > Organizational Expense: $200,000 maximum (expected to be materially lower) > > On Oct 18, 2016, at 9:06 AM, Jeffrey E. <[email protected]> wrote: » deal terms ? documents? > > On Tue, Oct 18, 2016 at 8:18 AM, Aaron Moskowitz < > wrote: » Jeff > > glad we had the chance to speak over the weekend. I wanted to send you our marketing presentation and summary. If like to speak more about health tech, the future of medicine and how we're approaching the space, please let me know. Feel free to share these documents with anyone interested in this space. My partner and I are in NYC often and would be more than happy to sit down. > > Sincerely, > > Aaron Moskowitz » please note >> > The information contained in this communication is >> > confidential, may be attorney-client privileged, may >> > constitute inside information, and is intended only for > > the use of the addressee. It is the property of > > JEE > > Unauthorized use, disclosure or copying of this > > communication or any part thereof is strictly prohibited >> > and may be unlawful. If you have received this >> > communication in error, please notify us immediately by >> > return e-mail or by e-mail to [email protected], and > > destroy this communication and all copies thereof, > > including all attachments. copyright -all rights reserved > -- > please note EFTA01057146 > The information contained in this communication is > confidential, may be attorney-client privileged, may > constitute inside information, and is intended only for > the use of the addressee. It is the property of > JEE > Unauthorized use, disclosure or copying of this > communication or any part thereof is strictly prohibited > and may be unlawful. If you have received this > communication in error, please notify us immediately by > return e-mail or by e-mail to [email protected], and > destroy this communication and all copies thereof, > including all attachments. copyright -all rights reserved please note The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of JEE Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to [email protected], and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved EFTA01057147